Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Fluvastatin enhances IL-33-mediated mast cell IL-6 and TNF production

Cellular Immunology(2021)10.1016/j.cellimm.2021.104457Source: DataRank Database

Fluvastatin enhances IL-33-mediated mast cell IL-6 and TNF production is a research paper published in Cellular Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.37)OA: greenTopics (63)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Elizabeth Motunrayo Kolawole ORCID,Amina Abdul Qayum,Tamara T. Haque ORCID,Heather L. Caslin ORCID,Daniel Abebayehu ORCID

Live enrichment

PubMed:34883342 PMC:PMC8782378 OpenAlex:https://openalex.org/W3216072127

National Institutes of Health

Grant: R01AI138495

National Institutes of Health

Grant: R21AI138494

NIDDK NIH HHS

Grant: U2C DK129500

NIDDK NIH HHS

Grant: TL1 DK132771

NIAID NIH HHS

Grant: R01 AI164710

FWCI

0.37

Citation Percentile

0.5%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8782378

publisherhttps://api.elsevier.com/content/article/PII:S0008874921001763?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0008874921001763?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cellimm.2021.104457

Fields of Study

IL-33, ST2, and ILC PathwaysMast cells and histamineEosinophilic Disorders and SyndromesAnimalsCells, CulturedFluvastatinHumansHydroxymethylglutaryl-CoA Reductase InhibitorsImmunoglobulin EInflammationInterleukin-33Interleukin-6Killer Cells, NaturalMacrophagesMast CellsMevalonic AcidMiceMice, Inbred BALB CMice, Inbred C57BLPeritonitisPrenylationStem Cell FactorTerpenesTranscription Factor RelATranscription, GeneticTumor Necrosis Factor-alpha

MeSH Terms

Interleukin-33FluvastatinAnimalsCells, CulturedHumansImmunoglobulin EInflammationKiller Cells, NaturalMacrophagesMast CellsMevalonic AcidMice, Inbred BALB CMice, Inbred C57BLPeritonitisTerpenesTranscription, GeneticTumor Necrosis Factor-alphaInterleukin-6Stem Cell FactorHydroxymethylglutaryl-CoA Reductase InhibitorsMiceTranscription Factor RelAPrenylation

Keywords

FluvastatinMast cellMevalonic acidTumor necrosis factor alphaBiologyCytokineInflammationPharmacologyImmunologyReductaseBiochemistryAllergyStatinIl-33

Fluvastatin enhances IL-33-mediated mast cell IL-6 and TNF production

FAIR Checklist

Authors (16)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)